IG Group Holdings plc
03 June 2005
3 June 2005
IG Group Holdings plc
THIS ANNOUNCEMENT IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION
IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA OR JAPAN
IG Group Holdings plc ('IG'), announces that in relation to the Global Offer of
Ordinary Shares of 0.005p each, UBS Limited ('UBS') has given notice of the
exercise of the Overallotment Option in respect of 7,950,659 Ordinary Shares,
taking the total number of Ordinary Shares sold pursuant to the Global Offer to
191,219,713. As a result of the exercise of the Overallotment Option, net
proceeds of approximately £9.5 million are receivable by the institutional
investors that provided the Overallotment Option. IG will receive none of the
net proceeds arising from the exercise of the Overallotment Option.
Terms used in this announcement have the same meanings as defined in IG's price
range prospectus dated 13 April 2005 and the supplementary prospectus dated 28
April 2005, as appropriate.
This document does not constitute, and should not be construed as, an offer to
sell or the solicitation or inducement of an offer to buy ordinary shares in IG.
Any offer, solicitation of an offer or invitation to acquire Ordinary Shares is
made by means of the prospectus dated 13 April 2005 and the supplementary
prospectus dated 28 April 2005 each relating to IG and any acquisition of
Ordinary Shares should be made solely on the basis of the information contained
in those documents and any supplements thereto. The price and value of shares
can go down as well as up. Persons needing advice should consult a professional
adviser.
UBS, Bridgewell Limited, Numis Securities Limited and Lexicon Partners Limited
are acting for IG and for no one else in connection with the offer of shares in
IG and none of UBS, Bridgewell Limited, Numis Securities Limited or Lexicon
Partners Limited will be responsible to anyone other than IG for providing the
protections afforded to their respective clients or for providing advice in
relation to the offer of shares in IG or any other matter referred to herein.
This document, and any materials attached hereto, are not an offer of securities
for sale in the United States. The shares in IG are not being registered under
the US Securities Act of 1933, as amended (the 'Securities Act') and may not be
offered or sold in the United States (as such term is defined in Regulation S
under the Securities Act) unless they are registered or exempt from
registration. No public offering of the shares in IG is being made in the United
States. This document is not for distribution in or into the United States,
Canada, Australia or Japan. No money, securities or other consideration is being
solicited by this document or any materials attached hereto or the information
they contain in the United States or any other jurisdiction in which such offer
is not authorised or to any person to whom it is unlawful to make such an offer
or invitation.
Stabilisation/FSA
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.